ArticleEuropean journal of nuclear medicine and molecular imaging2025

A visual whole-body tumor-burden classification based on PSMA PET/CT to predict response to novel androgen receptor signaling inhibitors for metastatic hormone-sensitive prostate cancer patients.

Xuhe Liao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.